Scaffold Engineering for Multispecific Binding

Beyond Monospecificity

Most computational binder design focuses on a single target. However, therapeutic applications increasingly demand multispecific molecules — bispecific engagers, multi-target inhibitors, and conditional logic gates. Scaffold engineering is the discipline of designing protein frameworks that can accommodate multiple binding functions without mutual interference.

Scaffold Selection Criteria

A successful multispecific scaffold must satisfy several constraints:

1. Thermodynamic stability — the scaffold must tolerate surface mutations without unfolding. AffiniBind™ screens scaffolds with ΔG_folding ≤ −8 kcal/mol.
2. Structural rigidity — flexible scaffolds allow paratope cross-talk; rigid frameworks maintain independent binding.
3. Accessible surface area — sufficient solvent-exposed area to accommodate multiple binding interfaces.
4. Expression yield — the final multispecific construct must express solubly in a production host (typically E. coli or HEK293).

Paratope Placement Strategies

Three strategies for placing multiple binding functions on a single scaffold:

Terminal Fusion

Fusing binding domains at the N- and C-termini of a central scaffold. Simplest to implement but risks inter-domain steric clash.

Surface Grafting

Introducing binding residues onto opposite faces of a symmetric scaffold (e.g., a homodimer or symmetric β-barrel). Provides spatial separation but constrains scaffold choice.

Loop Replacement

Replacing solvent-exposed loops with binding-competent sequences. Enables up to 4–6 independent paratopes on a single scaffold but requires careful loop-length optimization.

Interface Crosstalk

The key challenge in multispecific design is preventing paratope A from interfering with paratope B:

• Electrostatic isolation — placing paratopes with opposing charge profiles on separated faces.
• Steric separation — ensuring a minimum center-to-center distance (≥25 Å) between paratope interfaces.
• Folding cooperativity — confirming that individual paratope mutations do not destabilize the scaffold core.

Validation of Multispecifics

Multispecific binders require compound validation:

• Simultaneous binding — SPR co-injection experiments confirming both targets can bind concurrently.
• No cross-reactivity — each paratope shows no detectable binding to the other's target.
• Stoichiometry confirmation — SEC-MALS or native MS confirming 1:1:1 complex formation.

---

Scaffold engineering is an active area of development at WeaveSeq. View open targets to see current multispecific design projects.